The role of pancreatic duodenum homeobox protein-1 in the development of diabetes mellitus

Drug News and Perspectives

Volumn 15, Issue 8, 2002, Pages 491-497

  Habener, Joel F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INSULIN; TRANSCRIPTION FACTOR PDX 1;

ADULT; AMINO ACID SEQUENCE; CELL FUNCTION; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SCREENING; HUMAN; INSULIN SYNTHESIS; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGANOGENESIS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEQUENCE ANALYSIS;

EID: 0036826545     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2002.15.8.740224     Document Type: Review

References (56)

1. Krumlauf, R. Hox genes in vertebrate development. Cell 1994, 78: 191-201.
2. Habener, J.F. and Stoffers, D.A. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Assoc Am Physicans 1998, 110: 12-21.
3. Edlund, H. Transcribing pancreas. Diabetes 1998, 47: 1817-23.
4. Habener, J.F. Glucagon-like peptide-1 agonist stimulation of beta-cell growth and differentiation. Curr Opin Endocrinol Diabetes 2001, 8: 74-81.
5. McKinnon, C.M. and Docherty, K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 2001, 44: 1203-14.
6. Hui, H. and Perfetti, R. Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol 2002, 146: 129-41.
7. Peers, B., Shamm, S., Johnson, T. et al. The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: Importance of the FPWMK motif and of the homeodomain. Mol Cell Biol 1995, 15: 7091-7.
8. Waeber, G., Thompson, N., Nicod P. et al. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996, 10: 1327-34.
9. Watada, H., Kajimoto, Y., Umayahara, Y. et al. The human glucokinase gene beta-cell-type promoter: An essential role of insulin promoter factor I/PDX-1 in its activation in HIT-T15 cells. Diabetes 1996, 45: 1478-88.
10. Kaneto, H. Miyagawa, J., Kajimoto, Y. et al. Expression of heparin-binding epidermal growth factor-like factor during pancreas development. A potential role of PDX-1 in transcriptional activation. J Biol Chem 1997, 272: 29137-43.
11. Serup, P., Jensen, J., Andersen, F.G. et al. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc Natl Acad Sci USA 1996, 93: 9015-20.
12. Jonsson, J., Carlsson, L., Edlund, T. et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371: 606-9.
13. Stoffers, D.A., Zinkin, N.T., Stanojevic, V. et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 coding region. Nat Genet 1997, 15: 106-10.
14. Stoffers, D.A., Ferrer, J., Clarke, W.L. et al. Early-onset type-II diabetes mellitus (MODY4) linked to IPF-1. Nat Genet 1997. 17: 138-9.
15. Frayling, T.M., Evans, J.C., Bulman, M.P. et al. Beta cell genes and diabetes: Molecular and clinical charaterization of mutations in transcription factors. Diabetes 2001, 50: S94-100.
16. Tsigos, C., Kyrou, I. and Raptis, S.A. Monogenic forms of obesity and diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15: 241-53.
17. Yamagata, K., Furuta, H., Oda, N. et al. Mutations in the hepatocyte nuclear factor-4a gene in maturity-onset diabetes of the young (MODY1). Nature 1996, 384: 458-60.
18. Yamagata, K., Oda, N., Kalsaki, P.J. et al. Mutations in the hepatocyte nuclear factor-1a gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384: 455-60.
19. Horikawa, Y., Iwasaki, N. and Hara, M. Mutation in hepatocyte nuclear factor-1-beta gene (TCF2) associated with MODY. Nat Genet 1997, 17: 384-5.
20. Malecki, M.T., Jhala, U.S., Antonellis, A. et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999, 23: 323-8.
21. Vionnet, N., Stoffel, M., Takeda, J. et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992, 356: 721-2.
22. Stoffers, D.A., Stanojevic, V. and Habener, J.F. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 1998, 102: 232-41.
23. Clocquet, A.R., Egan, J.M., Stoffers, D.A. et al. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene). Diabetes 2000, 49: 1856-64.
24. Schwitzgebel, V.M., Mamin, A., Brun, T. et al. Decreased IPF1 level due to compound heterozygous mutation leads to agenesis of human pancreas. In: 62nd ADA Ann Meeting Sci Ses (June 14-18, 2002. San Francisco, CA, USA). 2002: Abst. P1-26.
25. Dutta, S., Bonner-Weir, S., Montminy, M. et al. Regulatory factor linked to late-onset diabetes? Nature 1998, 392: 560.
26. Ahlgren, U., Jonsson, J., Jonsson, L. et al. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998, 12: 1763-8.
27. Thomas, M.K., Devon, O.N., Lee, J.H. et al. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest 2001. 108: 319-29.
28. Hani, E.H., Stoffers, D.A., Chevre, J.C. et al. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 1999, 104: R41-8.
29. Waeber, G., Deplanque, J., Bonny, C. et al. The gene MAPK81P1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 2000, 24: 291-5.
30. Chevre, J.C., Hani, E.H., Stoffers, D.A. et al. Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes 1998, 47: 843-4.
31. MacFarlane, W.M., Frayling, T.M., Ellard, S. et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999, 104: R33-9.
32. Weng, J., Macfarlane, W.M., Lehto, M. et al. Fanctional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia 2001, 44: 249-58.
33. Hansen, L., Urioste, S., Petersen, H.V. et al. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in Caucasians. J Clin Endocrinol Metab 2000, 85: 1323-6.
34. Inoue, H., Riggs, A.C., Tanizawa, Y. et al. Isolation, characterization, and chromosomal mapping of the human insulin promoter factor 1 (IPF-1) gene. Diabetes 1996, 45: 789-94.
35. Yamada, K., Yuan, X., Ishiyama, S. et al. Identification of a single nucleotide insertion polymorphism in the upstream region of the insulin promoter factor-1 gene: All association study with diabetes mellitus. Diabetologia 1998, 41: 603-5.
36. Silver, K. and Shetty, A. IPF-1 gene variation and the development of type 2 diabetes. Mol Genet Metab 2002, 75: 287-9.
37. Sakuraba, H., Mizukami, H., Yagihashi, N. et al. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 2002, 45: 85-96.
38. Butler, A.E., Janson, J., Bonner-Weir, S. et al. Decreased beta cell mass in patients with type 2 diabetes mellitus. In: 62nd ADA Ann Meeting Sci Ses (June 14-18, 2002. San Francisco, CA, USA) 2002: Abst, 1502-P.
39. Seufert, J., Weir, G.C. and Habener, J.F. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancerbinding protein beta and islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. J Clin Invest 1998, 101: 2528-39.
40. Harmon, J.S., Gleason, C.E., Tanaka, Y. et al. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 1999, 48: 1995-2000.
41. Bonny, C., Roduit, R., Gremlich, S. et al. The loss of GLUT2 expression in the pancreatic beta-cells of diabetic db/db mice is associated with an impaired DNA-binding activity of islet-specific trans-acting factors. Mol Cell Endocrinol 1997, 135: 59-65.
42. Finegood, D.T., Scaglia, L. and Bonner-Weir, S. Dynamics of beta-cell mass in the growing rat pancreas: Estimation with a simple mathematical model. Diabetes 1995, 44: 249-56.
43. Ramiya, V.K., Maraist, M., Arfors, K.E. et al. Reversal of insulin-dependent diabetes using islets generated in vivo from pancreatic stem cells. Nat Med 2000, 6: 278-82.
44. Bonner-Weir, S., Taneja, M., Weir, G.C. et al. In vivo cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000, 97: 7999-8004.
45. Zulewski, H., Abraham, E.J., Gerlach, M.J. et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001, 50: 521-33.
46. Abraham, E.J., Leech, C.A., Lin, J. et al. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulinproducing cells. Endocrinology 2002, 143: 3152-61.
47. Hui, H., Wright, C. and Perfetti, R. Glucagon-like peptide 1 induces drifferentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 2001, 50: 785-96.
48. Stoffers, D.A., Kieffer, T.J., Hassain, M.A. et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 2000, 49: 741-8.
49. Xu, G., Stoffers, D.A., Habener, J.F. et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999, 48: 2270-6.
50. Ferber, S., Halkin, A., Cohen, H. et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000, 6: 568-72.
51. Yang, L., Li, S., Hatch, H. et al. In vitro transdifferentiation, of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 2002, 99: 8078-83.
52. Blau, H.M., Brazelton, T.R. and Weimann, J.M. The evolving concept of a stem cell: Entity or function? Cell 2001, 105: 829-41.
53. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L. et al. Pluripotency of mesenchymal stem cells derived from adult marrow: Nature 2002, 418: 41-9.
54. Fox, N., Priestley, G., Papayannopoulou, T. et al. Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest 2002, 110: 389-94.
55. Zhou, J., Wang, X., Pineyro, M.A. et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagonand insulin-producing cells. Diabetes 1999, 48: 2358-66.
56. Kieffer, T.J. and Habener, J.F. The glucagon-like peptides. Endocr Rev 1999, 20; 876-913.